Illumina, Inc. - Common Stock (NQ:ILMN)

273.04 +7.32 (+2.75%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery

November 25, 2025

Cambridge, MA & Barcelona, Spain – November 25, 2025 – A groundbreaking artificial intelligence model, popEVE, developed by a collaborative team of researchers from Harvard Medical School and the...

Via TokenRing AI

Topics Artificial Intelligence

The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

Illumina Inc (NASDAQ:ILMN) Presents a Compelling Case for Value Investors ↗

November 19, 2025

Illumina (ILMN) offers strong value with low valuation metrics, high profitability, and solid financial health, making it an intriguing stock for value investors.

Via Chartmill

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

November 18, 2025

Illumina has been on fire lately. In the past six months alone, the company’s stock price has rocketed 47%, reaching $121.93 per share. This was partly due to its solid quarterly results, and the...

Via StockStory

3 Unpopular Stocks with Warning Signs

November 16, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

1 Momentum Stock with Promising Prospects and 2 We Avoid

November 13, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

Cisco, Morgan Stanley, FTAI Aviation And A Health Care Stock On CNBC's 'Final Trades' ↗

November 11, 2025

On CNBC's "Halftime Report," Cerity Partners' Jim Lebenthal named Cisco Systems as his final trade and that the fundamentals justify it.

Via Benzinga

Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes

November 11, 2025

Nvidia's (NASDAQ: NVDA) recent stock performance has been a whirlwind of soaring highs and sharp corrections, acting as a potent barometer for the broader Wall Street landscape as of November 11, 2025....

Via MarketMinute

Topics Artificial Intelligence Economy Law Enforcement

AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps

November 10, 2025

The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable...

Via TokenRing AI

Topics Artificial Intelligence

1 Profitable Stock Worth Investigating and 2 Facing Headwinds

November 06, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

5 Revealing Analyst Questions From Illumina’s Q3 Earnings Call

November 06, 2025

Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit expectations, with positive market reaction following the report. Management...

Via StockStory

Topics Earnings

10x Genomics Earnings: What To Look For From TXG

November 04, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors should know.

Via StockStory

PacBio Earnings: What To Look For From PACB

November 03, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday after market close. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Illumina (ILMN) Stock Trades Down, Here Is Why

November 03, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.4% in the afternoon session after its negative momentum continued as Barclays maintained its Underweight recommendation on the stock. The...

Via StockStory

Topics Artificial Intelligence Supply Chain

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗

November 03, 2025

Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China growth in 2025.

Via Benzinga

Topics ETFs

Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? ↗

November 02, 2025

Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results.

Via Benzinga

Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results ↗

October 31, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 31, 2025

Via Benzinga

Why Illumina (ILMN) Stock Is Up Today

October 31, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 22.4% in the afternoon session after it reported third-quarter 2025 financial results that beat profit expectations and raised its full-year...

Via StockStory

Topics Economy Government World Trade

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars ↗

October 31, 2025

Illumina shares rise after posting Q3 earnings and revenue above estimates, raising 2025 guidance and showing growth in clinical sequencing markets.

Via Benzinga

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗

October 31, 2025

Via Benzinga

ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance

October 31, 2025

Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share...

Via StockStory

Illumina Inc (NASDAQ:ILMN) Surpasses Profit Expectations in Q3 2025, Sparking 8.6% Stock Rally ↗

October 30, 2025

Illumina (ILMN) Q3 2025 earnings beat profit estimates, sending shares up 8.6%. Strong EPS of $1.34 on flat revenue impressed investors.

Via Chartmill

Topics Earnings

Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations

October 30, 2025

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share was 14.7% above...

Via StockStory

What To Expect From Illumina’s (ILMN) Q3 Earnings

October 28, 2025

Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Nvidia Rockets Towards $5 Trillion Valuation, Reshaping the Global Tech Landscape

October 28, 2025

As of October 2025, Nvidia (NASDAQ: NVDA) stands on the precipice of a historic $5 trillion market valuation, a testament to its unparalleled dominance in the artificial intelligence (AI) and...

Via MarketMinute

Topics Artificial Intelligence Economy

Looking Into Illumina Inc's Recent Short Interest ↗

October 22, 2025

Via Benzinga

Undervalued Opportunity: A Deep Dive into Illumina Inc (ILMN) ↗

October 22, 2025

Illumina (ILMN) presents a strong value investment case with attractive valuation, high profitability, and solid financial health, trading below industry peers.

Via Chartmill

JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades' ↗

October 21, 2025

JPMorgan is still Joshua Brown's favorite long-term investment, supported by strong Q3 earnings. Others also favor Illumina, Columbia & Alibaba.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.